medroxyprogesterone DMPA injection
Selected indexed studies
- Injectable contraception. (Clin Obstet Gynecol, 1989) [PMID:2525977]
- Injectable contraception. (Semin Reprod Med, 2010) [PMID:20352562]
- Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study. (Contraception, 2017) [PMID:28673645]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Injectable contraception. (1989) pubmed
- Injectable contraception. (2010) pubmed
- Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study. (2017) pubmed
- Feasibility and acceptability of DMPA-SC self-injection in Addis Ababa, Ethiopia: a mixed-methods study. (2025) pubmed
- Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting. (1993) pubmed
- Depo-Provera. (1993) pubmed
- Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment. (2025) pubmed
- An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA). (2020) pubmed
- Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC). (2022) pubmed
- Contraception Update: Progestin-Only Implants and Injections. (2017) pubmed